Cardiol Therapeutics Inc. Gains Losses On Change In Fair Value Of Derivatives
Cardiol Therapeutics Inc. (CRDL) reported Gains Losses On Change In Fair Value Of Derivatives of CAD 951.74 thousand for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Income Statement › Other Income
ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives · last filed 2026-03-31
| Period end | Gains Losses On Change In Fair Value Of Derivatives 12 month |
|---|---|
| 2025-12-31 | 951.74K CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 238.18K CAD 40-F · filed 2026-03-31 |
| 2023-12-31 | 181.72K CAD 40-F · filed 2025-03-31 |
| 2022-12-31 | 6.24M CAD 20-F · filed 2024-04-01 |
| 2021-12-31 | 4.92M CAD 20-F · filed 2024-04-01 |